- Home
- CENT vs DNTH Comparison
CENT vs DNTH Comparison
Compare CENT & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CENT | DNTH |
|---|---|---|
| Founded | 1955 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CENT | DNTH |
|---|---|---|
| Price | $33.31 | $44.24 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $50.00 | ★ $68.00 |
| AVG Volume (30 Days) | 88.7K | ★ 765.4K |
| Earning Date | 11-24-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.41 | N/A |
| EPS | ★ 2.55 | N/A |
| Revenue | ★ $3,129,064,000.00 | $3,078,000.00 |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $2.10 | N/A |
| P/E Ratio | $13.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.77 | $13.37 |
| 52 Week High | $43.88 | $45.46 |
Technical Indicators
Market Signals| Indicator | CENT | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 65.78 |
| Support Level | $33.18 | $42.00 |
| Resistance Level | $34.24 | $45.46 |
| Average True Range (ATR) | 1.05 | 2.00 |
| MACD | 0.18 | 0.13 |
| Stochastic Oscillator | 54.15 | 79.49 |
Price Performance
Historical ComparisonAbout CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.